Larimar Therapeutics Inc.
LRMR | NASDAQ
$3.87
+$0.04 (+1.04%)
Sep 22, 2026, 12:19 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 80K | 81K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -80K | -81K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -34.35M | -31.12M | -64.02M | -49.5M | -27.79M | -31.19M | -31.29M | -18.26M | -24.6M | -16.73M | -14.16M | -10.34M | -9.62M | -7.64M | -10.44M | -8.51M | -8.69M | -8.89M | -9.09M | -16.73M | -12.54M | -12.11M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -32.78M | -29.61M | -62.5M | -47.71M | -26.18M | -29.28M | -28.82M | -15.5M | -21.63M | -14.65M | -12.99M | -9.06M | -8.37M | -6.53M | -9.43M | -8.32M | -8.67M | -8.94M | -9.13M | -16.81M | -12.61M | -12.09M |
Net Income | -32.78M | -29.61M | -62.5M | -47.71M | -26.18M | -29.28M | -28.82M | -15.5M | -21.63M | -14.65M | -12.99M | -9.06M | -8.37M | -6.53M | -9.43M | -8.32M | -8.67M | -8.94M | -9.13M | -16.81M | -12.61M | -12.09M |
Selling & General & Admin | 6.35M | 6.09M | 4.65M | 4.67M | 4.42M | 4.64M | 4.56M | 4.35M | 4.92M | 3.8M | 3.51M | 3.75M | 3.75M | 3.08M | 3.22M | 2.93M | 3.04M | 3.08M | 2.79M | 2.7M | 3.44M | 3.13M |
Research & Development | 28M | 25.03M | 59.37M | 44.93M | 23.37M | 26.55M | 26.74M | 13.92M | 19.68M | 12.86M | 10.57M | 6.59M | 5.88M | 4.56M | 7.22M | 5.58M | 5.64M | 5.81M | 6.29M | 14.03M | 9.1M | 8.97M |
Other Expenses | n/a | n/a | n/a | -100K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 34.35M | 31.12M | 64.02M | 49.5M | 27.79M | 31.19M | 31.29M | 18.26M | 24.6M | 16.65M | 14.08M | 10.34M | 9.62M | 7.64M | 10.44M | 8.51M | 8.69M | 8.89M | 9.09M | 16.73M | 12.54M | 12.11M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | 100K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 34.35M | 31.12M | 64.02M | 49.5M | 27.79M | 31.19M | 31.29M | 18.26M | 24.6M | 16.73M | 14.16M | 10.34M | 9.62M | 7.64M | 10.44M | 8.51M | 8.69M | 8.89M | 9.09M | 16.73M | 12.54M | 12.11M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 103.88M | 85.18M | 85.18M | 78.32M | 64.03M | 63.96M | 63.81M | 63.81M | 63.8M | 53.55M | 43.91M | 43.9M | 43.9M | 43.9M | 23.99M | 22.23M | 18.34M | 18.34M | 18.34M | 18.29M | 16M | 16M |
Shares Outstanding (Diluted) | 103.88M | 85.18M | 85.18M | 78.32M | 64.03M | 63.96M | 63.81M | 63.81M | 63.8M | 53.55M | 43.91M | 43.9M | 43.9M | 43.9M | 23.99M | 22.23M | 18.34M | 18.34M | 18.34M | 18.29M | 16M | 16M |
EPS (Basic) | -0.30 | -0.35 | -0.73 | -0.61 | -0.41 | -0.46 | -0.45 | -0.24 | -0.34 | -0.27 | -0.30 | -0.21 | -0.19 | -0.12 | -0.35 | -0.37 | -0.47 | -0.49 | -0.50 | -0.92 | -0.79 | -0.76 |
EPS (Diluted) | -0.30 | -0.35 | -0.73 | -0.61 | -0.41 | -0.46 | -0.45 | -0.24 | -0.34 | -0.27 | -0.30 | -0.21 | -0.19 | -0.12 | -0.35 | -0.37 | -0.47 | -0.49 | -0.50 | -0.92 | -0.79 | -0.76 |
EBITDA | -32.72M | -29.55M | -62.41M | -47.62M | -26.1M | -29.19M | -28.75M | -15.43M | -21.54M | -14.57M | -12.91M | -8.99M | -8.29M | -6.45M | -9.35M | -8.24M | -8.59M | -8.86M | -9.05M | -16.72M | -12.53M | -12.03M |
EBIT | -32.78M | -29.61M | -62.5M | -47.71M | -26.18M | -29.28M | -28.82M | -15.5M | -21.63M | -14.65M | -12.99M | -9.06M | -8.37M | -6.53M | -9.43M | -8.32M | -8.67M | -8.94M | -9.13M | -16.81M | -12.61M | -12.11M |
Depreciation & Amortization | 62K | 64K | 87K | 88K | 87K | 88K | 77K | 74K | 87K | 80K | 81K | 76K | 76K | 78K | 78K | 77K | 81K | 82K | 88K | 88K | 77K | 73K |
Add to Watchlist
Select watchlists to add or remove LRMR